Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network meta-analysis of transcriptome expression changes in different manifestations of dengue virus infection. | BMC Genomics | 2022 | 35220956 | PubTator, text mining | PubMed |
| Leptin-mediated proinflammatory bone marrow environment in acquired aplastic anemia. | Cytokine | 2022 | 35217430 | PubTator, text mining | PubMed |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. | Cell | 2022 | 35216673 | PubTator, text mining | PubMed |
| Interaction between the Hepatitis B Virus and Cellular FLIP Variants in Viral Replication and the Innate Immune System. | Viruses | 2022 | 35215970 | PubTator, text mining | PubMed |
| Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease. | Viruses | 2022 | 35215967 | PubTator, text mining | PubMed |
| The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? | Front Immunol | 2022 | 35211123 | PubTator, text mining | PubMed |
| Persistent Changes of Peripheral Blood Lymphocyte Subsets in Patients with Oral Squamous Cell Carcinoma. | Healthcare (Basel) | 2022 | 35206956 | PubTator, text mining | PubMed |
| The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer. | Diagnostics (Basel) | 2022 | 35204406 | PubTator, text mining | PubMed |
| An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation. | Diagnostics (Basel) | 2022 | 35204399 | PubTator, text mining | PubMed |
| Human Hair Follicle-Derived Mesenchymal Stromal Cells from the Lower Dermal Sheath as a Competitive Alternative for Immunomodulation. | Biomedicines | 2022 | 35203464 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Polarised Macrophages Derived from Induced Pluripotent Stem Cells. | Biomedicines | 2022 | 35203449 | PubTator, text mining | PubMed |
| Supervised and unsupervised learning to define the cardiovascular risk of patients according to an extracellular vesicle molecular signature. | Transl Res | 2022 | 35202881 | PubTator, text mining | PubMed |
| Regulation of influenza A virus infection by Lnc-PINK1-2:5. | J Cell Mol Med | 2022 | 35201667 | PubTator, text mining | PubMed |
| A Case of T/NK-Cell Post-Transplantation Lymphoproliferative Disease 7 Years after Heart Transplantation. | J Cardiovasc Dev Dis | 2022 | 35200692 | PubTator, text mining | PubMed |
| Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection. | Nat Commun | 2022 | 35197461 | PubTator, text mining | PubMed |
| Minding the message: tactics controlling RNA decay, modification, and translation in virus-infected cells. | Genes Dev | 2022 | 35193946 | PubTator, text mining | PubMed |
| Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum. | Br J Dermatol | 2022 | 35191018 | PubTator, text mining | PubMed |
| Alterations in the immune phenotype of thymectomized children and the development of atopic disorders after heart transplantation. | Pediatr Transplant | 2022 | 35187796 | PubTator, text mining | PubMed |
| The Emerging Role of RNA Modifications in the Regulation of Antiviral Innate Immunity. | Front Microbiol | 2022 | 35185855 | PubTator, text mining | PubMed |
| Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses. | Cancer Immunol Res | 2022 | 35181787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=54